Search Results

You are looking at 1 - 2 of 2 items for

  • Author: D M Brocht x
  • Refine by access: All content x
Clear All Modify Search
J P McMurtry
Search for other papers by J P McMurtry in
Google Scholar
PubMed
Close
,
G L Francis
Search for other papers by G L Francis in
Google Scholar
PubMed
Close
,
F Z Upton
Search for other papers by F Z Upton in
Google Scholar
PubMed
Close
,
G Rosselot
Search for other papers by G Rosselot in
Google Scholar
PubMed
Close
, and
D M Brocht
Search for other papers by D M Brocht in
Google Scholar
PubMed
Close

Abstract

The development of a homologous radioimmunoassay (RIA) for chicken insulin-like growth factor-I (cIGF-I) and its use to investigate the developmental changes in IGF-I in the chicken and turkey is described. A doubleantibody RIA has been developed using recombinantly derived cIGF-I as antigen, radiolabelled tracer and standard. The resulting immunoassay has a minimum detection limit of 0·035 ng and effective dose of 2·5 ng. Dose–response curves of chicken and turkey plasma and tissue extracts were parallel with cIGF-I standard. The antiserum is specific for IGF-I as no cross-reactivity with chicken IGF-II, insulin, glucagon, gastrin or avian pancreatic polypeptide was observed. We have also established that acid/ethanol extraction of chicken and turkey plasma reduced possible interference of IGF-binding proteins (IGFBPs) in the RIA. Comparison of IGF-I immunoactivity in unextracted and acid/ethanol-extracted samples following gel filtration under acidic and neutral conditions indicates that the cIGFBPs may be acid-labile. Analyses of samples from growing chickens and turkeys using the homologous avian reagents revealed higher IGF-I concentrations than if the IGF were quantified using heterologous mammalian-derived reagents. A similar pattern was observed when tissue extracts were assayed for IGF-I content. The application of the homologous RIA to monitor blood and tissue IGF-I levels during embryonic development and posthatch growth in avian species will provide more accurate comparisons of results from studies on the role of IGF-I in growth and metabolism of domestic birds.

Journal of Endocrinology (1994) 142, 225–234

Restricted access
J P McMurtry
Search for other papers by J P McMurtry in
Google Scholar
PubMed
Close
,
G L Francis
Search for other papers by G L Francis in
Google Scholar
PubMed
Close
,
Z Upton
Search for other papers by Z Upton in
Google Scholar
PubMed
Close
,
P E Walton
Search for other papers by P E Walton in
Google Scholar
PubMed
Close
,
G Rosselot
Search for other papers by G Rosselot in
Google Scholar
PubMed
Close
,
T J Caperna
Search for other papers by T J Caperna in
Google Scholar
PubMed
Close
, and
D M Brocht
Search for other papers by D M Brocht in
Google Scholar
PubMed
Close

Abstract

The metabolic clearance of chicken IGF-I (cIGF-I), cIGF-II, human IGF-I (hIGF-I), and hIGF-II was examined in the chicken using 125I-labelled growth factors. Superose-12 chromatography of plasma collected at 7·5 min post-infusion revealed peaks of radioactivity corresponding to 150 and 43 kDa and unbound tracer. Statistical analysis of trichloroacetic acid (TCA)-precipitable radioactivity in sequential plasma samples as well as following chromatography of the same samples revealed that clearance of the radiolabelled peptides followed an apparent triphasic pattern. The close similarity of the individual chromatographically defined pools in their clearance rate compared with the three components described by TCA precipitation strongly suggested their identity. Both free 125I-labelled cIGF-II (3·11 min) and hIGF-II (3·01 min) were cleared at a greater rate than their IGF-I counterparts. Unbound hIGF-I was cleared at a greater rate than cIGF-I (4·45 vs 5·66 min respectively). A similar pattern for clearance was evident in the radiolabelled growth factors associated with the 43 kDa component, although at a longer half-life. There was no difference in the apparent clearance of the radiolabelled growth factors associated with the 150 kDa component between IGF-I or -II or between species. Analysis of the chromatographic profiles of radioactive IGF-I peptides complexed to serum proteins versus those bound to labelled IGF-II peptides revealed the presence of a large molecular mass binding protein in vivo. Ligand blotting of chicken serum determined that a binding protein with a mass of 70 kDa was detectable with 125I-IGF-II probes only, and was not present in pig serum. In addition, tissue uptake of 125I-cIGF-I and -II was evaluated. Similar patterns of tissue distribution and uptake were observed for 125I-cIGF-I and -II, except that cIGF-II uptake by the liver exceeded that of 125I-cIGF-I at 15 min post-infusion. The rank order of tissue distribution was as follows: kidney > testis > heart > liver > pancreas > small intestine> cartilage > bursa > gizzard > leg muscle > breast muscle > brain. We conclude from these studies that the clearance of IGFs from the compartments identified in blood and the potential target tissues is dependent on their interactions with IGF-binding proteins and receptors.

Journal of Endocrinology (1996) 150, 149–160

Restricted access